1
Chang, C. C., Lee, C. T., Lan, T. H., Ju, P. C., Hsieh, Y. H., & Lai, T. J. (2015). Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder. Psychiatry Res, 230(2), 575-580. doi:10.1016/j.psychres.2015.10.006
2
Ju, P. C., Chou, F. H., Lai, T. J., Chuang, P. Y., Lin, Y. J., Yang, C. W., & Tang, C. H. (2014). Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan. J Clin Psychopharmacol, 34(1), 23-29. doi:10.1097/JCP.0b013e3182a6a142
3
Double-Balloon Enteroscopy for Bleeding Meckel's Diverticulum in a Child Aged Less Than Four Years Gastrointestinal Endoscopy Volume 70, No. 2:2009Shan-Ming Chen, MD, Ching-Pin Lin, MD,Taichung,Taiwan
4
6-Gingerol Inhibits Growth of Colon Cancer Cell LoVo via Induction of G2/M Arrest Evidence-Based Complementary and Alternative Medicine Volume 2012 Ching-Pin Lin, Chun-Che Lin, and Gregory J. Tsay
5
Clinical Characteristics and Outcome in Norovirus Gastroenteritis The Indian Journal of Pediatrics(2014) Ching-Pin Lin, Shan-Ming Chen
6
Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome MOLECULAR MEDICINE REPORTS(2014) Jen-Wei Chou, Shan-Ming Chen, and Ching-Pin Lin
7
Anti-oxidant and anti-inflammatory effects of hydrogenrich water alleviate ethanol-induced fatty liver in mice World Gastroenterol 2017 Ching-Pin Lin, Wen-Chen Chuang, Fung-Jou Lu, Chih-Yen Chen
8
Ho LT, Yin WH, Chuang SY, Tseng WK, Wu YW, Hsieh IC, Lin TH, Li YH, Huang LC, Wang KY, Ueng KC, Fang CC, Pan WH, Yeh HI, Wu CC, Chen JW; Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry Investigators. Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan. PLoS One. 2015 Mar 10;10(3):e0116513.
9
Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA; ELIXA Investigators. (Ueng KC et al.). Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. Am Heart J. 2015 May;169(5):631-638.
10
Chou CH, Ueng KC, Liu YF, Wu CH, Yang SF, Wang PH. Impact of Intercellular Adhesion Molecule-1 Genetic Polymorphisms on Coronary Artery Disease Susceptibility in Taiwanese Subjects. Int J Med Sci. 2015 Jun 9;12(6):510-516.
